EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma

Tengda Huang iD, Hongying Chen, Hongyuan Pan, Tian Wu, Xiangyi Ren, Liwen Qin, Kefei Yuan, Fang He iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0315534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Tengda Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Vesicular Transport Proteins, Microfilament Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Project, Science and Technology Project of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hepatocellular carcinoma is one of the leading causes of cancer-related mortality worldwide. The actin-binding protein Girdin is overexpressed in various tumors, promoting tumorigenesis and progression. However, the exact mechanisms by which Girdin regulates liver cancer remain poorly understood.

Methods

This study comprehensively analyzed the expression level of Girdin in liver cancer and adjacent tissue, along with the correlation between Girdin expression and the clinical characteristics and prognosis of liver cancer. The analysis integrated data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Subsequently, Girdin expression was knocked down to elucidate its role in the progression of liver cancer. Transcriptome sequencing was employed to investigate the mechanistic underpinnings of Girdin’s regulatory impact on liver cancer. Additionally, the Comparative Toxicogenomics Database (CTD) was utilized to identify potential drugs or molecules for liver cancer treatment.

Results

The findings revealed elevated Girdin expression in liver cancer tissues, and heightened Girdin expression correlating with adverse clinical features and prognosis. Silencing of Girdin markedly impeded the proliferation and migration of hepatocellular carcinoma cells. Moreover, transcriptome sequencing demonstrated that silencing Girdin led to differential expression of 176 genes and inhibition of the PI3K/Akt signaling pathway, as well as its upstream pathways—Cytokine-cytokine receptor interaction and Chemokine signaling pathway. Ultimately, we propose that Imatinib Mesylate, Orantinib, Resveratrol, Sorafenib, and Curcumin may interact with Girdin, potentially contributing to the treatment of liver cancer.

Conclusion

This study reveals the association between Girdin and hepatocellular carcinoma, providing novel clues for future research and treatment of hepatocellular carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsVesicular Transport ProteinsMicrofilament ProteinsComputational BiologyGene Expression Regulation, NeoplasticHumansPrognosisSystems BiologyCell ProliferationCell MovementSignal TransductionCell Line, TumorMale

Substanzen

CCDC88A protein, humanVesicular Transport ProteinsMicrofilament Proteins

Autor:innen und Institutionen

  • Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
  • Cytology and Molecular Platform, Core Facilities of West China Hospital, Chengdu, China.
  • NHC Key Laboratory of Transplant Engineering and Immunology, Regenerative Medicine Research Center, Frontiers Science Center for Disease-related Molecular Network, West China Hospital of Sichuan University, Chengdu, Chi…
  • Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Tengda Huang, Fang He

Förderung

  • Key Research and Development Project, Science and Technology Project of Sichuan Province

Zitieren

APA

Huang, T., Chen, H., Pan, H., Wu, T., Ren, X., Qin, L., Yuan, K., & He, F. (2024). Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma. PLOS ONE. https://doi.org/10.1371/journal.pone.0315534

Vancouver

Huang T, Chen H, Pan H, Wu T, Ren X, Qin L, et al. Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma. PLOS ONE. 2024. doi:10.1371/journal.pone.0315534

BibTeX
@article{Huang2024,
  author = {Huang, Tengda and Chen, Hongying and Pan, Hongyuan and Wu, Tian and Ren, Xiangyi and Qin, Liwen and Yuan, Kefei and He, Fang},
  title = {Comprehensive analysis of bioinformatics and system biology reveals the association between Girdin and hepatocellular carcinoma},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0315534}
}
Kostenlos starten →